The following Life Sciences practice note Produced in partnership with Thomas Bjorn provides comprehensive and up to date legal information covering:
The term ‘technology transfer agreement’ is used as an umbrella term for a multitude of different types of agreements intended to cover the process of transferring the ownership or the right of use of a particular technology from one party to another.
Technology transfer agreements are vital instruments for ensuring the effective exploitation of existing technologies and for ensuring that new ones are developed through the collaboration between the different academic and commercial organisations in the life science sector.
This Practice Note looks at technology transfer agreements with a particular view to the type of additional provisions that would be of importance to the life science industries.
Many life science products are protectable under the patent system. Examples include biological materials, methods of their production, and therapeutic uses thereof. Given the significant expense of developing life science products and in particular therapeutics, patent protection in the Life sciences industry is of particular importance. Granted patents provide proprietors with an exclusive monopoly to recover costs associated with research and development, and are typically a requirement to secure financial investment.
Technology transfer is the process of transferring technology from one party to another, either for the purpose of transferring the full ownership to the technology as in the case of an assignment of a patent or for the purpose of transferring a
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Unlike many other countries, the UK has no unfair competition law. Brand owners seeking to prevent competitors from marketing ‘copycat’ products or using misleading advertising have to rely on a combination of different intellectual property rights. These rights include the common law right to
Community order requirementsCommunity order requirements are set out in the Criminal Justice Act 2003 (CJA 2003), as amended by the Legal Aid, Sentencing and Punishment of Offenders Act 2012 (LASPO 2012) and the Offender Rehabilitation Act 2014 (ORA 2014). Criminal Justice Act 2003, s 152(2)
Part 8 of the Corporation Tax Act 2009 (CTA 2009) is a specific corporation tax regime that applies exclusively to the gains and losses of intangible fixed assets. Note, however, that certain intangible fixed assets are excluded from the regime, see Practice Note: Excluded intangible fixed
Disposal and devolutionThe equity of redemption arises as soon as the mortgage is made. It is an interest in the land which the mortgagor can:•transfer, lease or mortgage inter vivos, or•by will (it passes on intestacy)No cloggingIt is a fundamental principle of a mortgage that there must be no clog
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.